ALIGNMENT HEALTHCARE INC (ALHC) Fundamental Analysis & Valuation

NASDAQ:ALHC • US01625V1044

Current stock price

21.66 USD
+2.99 (+16.01%)
At close:
21.85 USD
+0.19 (+0.88%)
After Hours:

This ALHC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. ALHC Profitability Analysis

1.1 Basic Checks

  • In the past year ALHC has reported negative net income.
  • In the past year ALHC had a positive cash flow from operations.
  • In the past 5 years ALHC always reported negative net income.
  • The reported operating cash flow has been mixed in the past 5 years: ALHC reported negative operating cash flow in multiple years.
ALHC Yearly Net Income VS EBIT VS OCF VS FCFALHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 100M -100M

1.2 Ratios

  • The Return On Assets of ALHC (-0.07%) is comparable to the rest of the industry.
  • Looking at the Return On Equity, with a value of -0.40%, ALHC is in line with its industry, outperforming 52.00% of the companies in the same industry.
  • ALHC has a Return On Invested Capital (2.29%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -0.07%
ROE -0.4%
ROIC 2.29%
ROA(3y)-13.82%
ROA(5y)-19.2%
ROE(3y)-74.31%
ROE(5y)-69.91%
ROIC(3y)N/A
ROIC(5y)N/A
ALHC Yearly ROA, ROE, ROICALHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100

1.3 Margins

  • ALHC has a Operating Margin of 0.37%. This is in the lower half of the industry: ALHC underperforms 64.00% of its industry peers.
  • ALHC's Gross Margin of 12.37% is on the low side compared to the rest of the industry. ALHC is outperformed by 68.00% of its industry peers.
  • In the last couple of years the Gross Margin of ALHC has declined.
Industry RankSector Rank
OM 0.37%
PM (TTM) N/A
GM 12.37%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.25%
GM growth 5Y-6.51%
ALHC Yearly Profit, Operating, Gross MarginsALHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 10 -10

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. ALHC Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ALHC is destroying value.
  • Compared to 1 year ago, ALHC has more shares outstanding
  • Compared to 5 years ago, ALHC has more shares outstanding
  • ALHC has a better debt/assets ratio than last year.
ALHC Yearly Shares OutstandingALHC Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
ALHC Yearly Total Debt VS Total AssetsALHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

  • An Altman-Z score of 5.45 indicates that ALHC is not in any danger for bankruptcy at the moment.
  • ALHC has a better Altman-Z score (5.45) than 88.00% of its industry peers.
  • The Debt to FCF ratio of ALHC is 2.86, which is a good value as it means it would take ALHC, 2.86 years of fcf income to pay off all of its debts.
  • ALHC has a better Debt to FCF ratio (2.86) than 71.00% of its industry peers.
  • ALHC has a Debt/Equity ratio of 1.80. This is a high value indicating a heavy dependency on external financing.
  • ALHC's Debt to Equity ratio of 1.80 is on the low side compared to the rest of the industry. ALHC is outperformed by 71.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.8
Debt/FCF 2.86
Altman-Z 5.45
ROIC/WACC0.27
WACC8.6%
ALHC Yearly LT Debt VS Equity VS FCFALHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M

2.3 Liquidity

  • ALHC has a Current Ratio of 1.71. This is a normal value and indicates that ALHC is financially healthy and should not expect problems in meeting its short term obligations.
  • ALHC has a Current ratio of 1.71. This is in the better half of the industry: ALHC outperforms 71.00% of its industry peers.
  • ALHC has a Quick Ratio of 1.71. This is a normal value and indicates that ALHC is financially healthy and should not expect problems in meeting its short term obligations.
  • ALHC's Quick ratio of 1.71 is fine compared to the rest of the industry. ALHC outperforms 74.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.71
Quick Ratio 1.71
ALHC Yearly Current Assets VS Current LiabilitesALHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. ALHC Growth Analysis

3.1 Past

  • ALHC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 98.51%, which is quite impressive.
  • Looking at the last year, ALHC shows a very strong growth in Revenue. The Revenue has grown by 46.06%.
  • The Revenue has been growing by 32.71% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)98.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%66.67%
Revenue 1Y (TTM)46.06%
Revenue growth 3Y40.16%
Revenue growth 5Y32.71%
Sales Q2Q%44.43%

3.2 Future

  • ALHC is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 248.11% yearly.
  • The Revenue is expected to grow by 27.43% on average over the next years. This is a very strong growth
EPS Next Y4562.5%
EPS Next 2Y536.03%
EPS Next 3Y321.18%
EPS Next 5Y248.11%
Revenue Next Year31.76%
Revenue Next 2Y28.82%
Revenue Next 3Y27.27%
Revenue Next 5Y27.43%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
ALHC Yearly Revenue VS EstimatesALHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2B 4B 6B 8B 10B
ALHC Yearly EPS VS EstimatesALHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.5 -0.5 1 -1

More info and screens

Find the best growth stocksShow best growing peers

3

4. ALHC Valuation Analysis

4.1 Price/Earnings Ratio

  • ALHC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • A Price/Forward Earnings ratio of 48.54 indicates a quite expensive valuation of ALHC.
  • ALHC's Price/Forward Earnings is on the same level as the industry average.
  • ALHC is valuated expensively when we compare the Price/Forward Earnings ratio to 23.10, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 48.54
ALHC Price Earnings VS Forward Price EarningsALHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -500 -1K -1.5K -2K

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALHC indicates a slightly more expensive valuation: ALHC is more expensive than 65.00% of the companies listed in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of ALHC is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 39.11
EV/EBITDA 77.48
ALHC Per share dataALHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as ALHC's earnings are expected to grow with 321.18% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y536.03%
EPS Next 3Y321.18%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ALHC Dividend Analysis

5.1 Amount

  • No dividends for ALHC!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ALHC Fundamentals: All Metrics, Ratios and Statistics

ALIGNMENT HEALTHCARE INC

NASDAQ:ALHC (4/7/2026, 6:00:03 PM)

After market: 21.85 +0.19 (+0.88%)

21.66

+2.99 (+16.01%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-26
Earnings (Next)04-30
Inst Owners95.34%
Inst Owner Change0%
Ins Owners3.49%
Ins Owner Change-7.94%
Market Cap4.43B
Revenue(TTM)3.95B
Net Income(TTM)-724.00K
Analysts85.26
Price Target25.96 (19.85%)
Short Float %8.64%
Short Ratio5.32
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)96.03%
Min EPS beat(2)67.92%
Max EPS beat(2)124.15%
EPS beat(4)4
Avg EPS beat(4)112.14%
Min EPS beat(4)61.17%
Max EPS beat(4)195.32%
EPS beat(8)7
Avg EPS beat(8)58.98%
EPS beat(12)10
Avg EPS beat(12)43.37%
EPS beat(16)13
Avg EPS beat(16)38.5%
Revenue beat(2)0
Avg Revenue beat(2)-0.86%
Min Revenue beat(2)-1%
Max Revenue beat(2)-0.73%
Revenue beat(4)2
Avg Revenue beat(4)1.06%
Min Revenue beat(4)-1%
Max Revenue beat(4)3.66%
Revenue beat(8)6
Avg Revenue beat(8)2.08%
Revenue beat(12)9
Avg Revenue beat(12)1.93%
Revenue beat(16)13
Avg Revenue beat(16)2.58%
PT rev (1m)1.45%
PT rev (3m)18.62%
EPS NQ rev (1m)-41.67%
EPS NQ rev (3m)-36.99%
EPS NY rev (1m)0%
EPS NY rev (3m)433.54%
Revenue NQ rev (1m)-1.19%
Revenue NQ rev (3m)0.24%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.38%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 48.54
P/S 1.12
P/FCF 39.11
P/OCF 31.62
P/B 24.68
P/tB 31.02
EV/EBITDA 77.48
EPS(TTM)-0.01
EYN/A
EPS(NY)0.45
Fwd EY2.06%
FCF(TTM)0.55
FCFY2.56%
OCF(TTM)0.68
OCFY3.16%
SpS19.33
BVpS0.88
TBVpS0.7
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.07%
ROE -0.4%
ROCE 2.9%
ROIC 2.29%
ROICexc N/A
ROICexgc N/A
OM 0.37%
PM (TTM) N/A
GM 12.37%
FCFM 2.87%
ROA(3y)-13.82%
ROA(5y)-19.2%
ROE(3y)-74.31%
ROE(5y)-69.91%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.25%
GM growth 5Y-6.51%
F-Score6
Asset Turnover3.7
Health
Industry RankSector Rank
Debt/Equity 1.8
Debt/FCF 2.86
Debt/EBITDA 7.14
Cap/Depr 87.86%
Cap/Sales 0.68%
Interest Coverage 1.07
Cash Conversion 309.34%
Profit Quality N/A
Current Ratio 1.71
Quick Ratio 1.71
Altman-Z 5.45
F-Score6
WACC8.6%
ROIC/WACC0.27
Cap/Depr(3y)135.68%
Cap/Depr(5y)133.25%
Cap/Sales(3y)1.39%
Cap/Sales(5y)1.51%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)98.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%66.67%
EPS Next Y4562.5%
EPS Next 2Y536.03%
EPS Next 3Y321.18%
EPS Next 5Y248.11%
Revenue 1Y (TTM)46.06%
Revenue growth 3Y40.16%
Revenue growth 5Y32.71%
Sales Q2Q%44.43%
Revenue Next Year31.76%
Revenue Next 2Y28.82%
Revenue Next 3Y27.27%
Revenue Next 5Y27.43%
EBIT growth 1Y114.62%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year753.4%
EBIT Next 3Y155.45%
EBIT Next 5Y98.73%
FCF growth 1Y1801.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y302.44%
OCF growth 3YN/A
OCF growth 5Y79.26%

ALIGNMENT HEALTHCARE INC / ALHC Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ALIGNMENT HEALTHCARE INC?

ChartMill assigns a fundamental rating of 4 / 10 to ALHC.


Can you provide the valuation status for ALIGNMENT HEALTHCARE INC?

ChartMill assigns a valuation rating of 3 / 10 to ALIGNMENT HEALTHCARE INC (ALHC). This can be considered as Overvalued.


Can you provide the profitability details for ALIGNMENT HEALTHCARE INC?

ALIGNMENT HEALTHCARE INC (ALHC) has a profitability rating of 1 / 10.


Can you provide the expected EPS growth for ALHC stock?

The Earnings per Share (EPS) of ALIGNMENT HEALTHCARE INC (ALHC) is expected to grow by 4562.5% in the next year.